Produced by Eurofins | Presented by Naturally Boulder
We all see the light at the end of the tunnel, but significant variables mean we’re not out of the woods yet. Local vaccination and infection rates are inconsistent across the US, COVID-19 variants continue to emerge and spread, and vaccine longevity isn’t entirely established. We must continue to mitigate risk to loved ones, employees, and communities—and ensure business continuity.
Now we’re “Testing for Negative”—focusing on prevention of infection and spread.
In this webinar, Eurofins medical director Dr. Travis Wilkes will discuss testing options that can provide a safety net as we move through each new phase of the pandemic.
This webinar will cover:
- Why experts recommend we keep testing
- Testing programs that balance your budget with your goals
- Proactive solutions for early COVID-19 detection—before it spreads
- Answers to frequently asked questions
LEARN FROM THE EXPERTS
Travis Wilkes, MD is the Medical Director for Eurofins SAFER@WORKTM and EmpowerDX overseeing medical affairs, research, and clinical test development. He has worked with Eurofins for 5 years. Since the pandemic he has played an instrumental role in the launch of the EmpowerDX at-home COVID-19 nasal PCR testing, at-home worn mask PCR testing and the development of SAFER@WORKTM solutions for reducing COVID-19 outbreak risks. In this position, he has worked closely with many companies on national and international strategies related to COVID-19. He has extensive experience in clinical medicine, the pharmaceutical industry, and the laboratory industry. He earned his Bachelor of Science from Emory University and his Medical Degree from the Medical University of South Carolina. Dr. Wilkes is Board Certified in Family Medicine.